Vaxart Inc

Vaxart Inc. is a company based in South San Francisco, California, specializing in the development of oral vaccine pills. The company currently employs 119 people and generated $50 million in revenue. Vaxart focuses on revolutionizing vaccine delivery through its innovative oral vaccine pill technology. These pills target pathogens at their entry points in the body, such as the mouth, nose, and gut, aiming to elicit robust immune responses. Vaxart is currently conducting Phase II trials for its oral vaccine candidates against COVID-19 and Norovirus. Vaxart distinguishes itself as the only company globally to have reached Phase II trials with a COVID-19 vaccine pill. Its technology offers a novel approach to vaccine administration, potentially improving accessibility and convenience compared to traditional intramuscular injections. To learn more about Vaxart and its groundbreaking oral vaccine technology, visit their website at vaxart.com.